linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet
- RxCUI
- 1243034
- RxNorm name
- linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet
- Display name
- linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet
- Full name
- linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Linagliptin and metformin hydrochloride | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | Novadoz Pharmaceuticals LLC | 5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | 1243034 |
| Jentadueto | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | f6dd9b86-0d18-95d4-2bc7-05591bfdd597 | 2024-06-27 | Boxed warning, Warnings, Adverse reactions | 1243034 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f6dd9b86-0d18-95d4-2bc7-05591bfdd597 | linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet | SCD | 45 | These highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. JENTADUETO ® (linagliptin and metformin hydrochloride tablets), for oral use Initial U.S. Approval: 2012 | 20240627 |
| f6dd9b86-0d18-95d4-2bc7-05591bfdd597 | linagliptin 2.5 MG / metFORMIN HCl 850 MG Oral Tablet | PSN | 45 | These highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. JENTADUETO ® (linagliptin and metformin hydrochloride tablets), for oral use Initial U.S. Approval: 2012 | 20240627 |
| 5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb | linagliptin 2.5 MG / metFORMIN HCl 850 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use LINAGLIPTIN and METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for LINAGLIPTIN and METFORMIN HYDROCHLORIDE TABLETS. LINAGLIPTIN and METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 2012 | 20251104 |
| 5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb | linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use LINAGLIPTIN and METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for LINAGLIPTIN and METFORMIN HYDROCHLORIDE TABLETS. LINAGLIPTIN and METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 2012 | 20251104 |